THRIVE related activities at EASL Congress 2024

THRIVE is an EU-founded initiative that brings together a strong and multidisciplinary team with 13 partners, from 8 countries, with complementary expertise in liver cancer research and in the use of cutting-edge technologies.

The overall aim of the THRIVE project is to improve the outcome of both paediatric and adult liver cancer patients by understanding at-risk populations, tumour-host molecular interactions, developing biomarkers for current therapies and identify novel and affordable and societally-accepted treatments to overcome resistance.

THRIVE Networking session

Title: Networking Session: Thrive
Presenter: Roser Pinyol
Session-Type: Networking
Topic: Liver Tumours
Room: Track Hub: Liver Tumours
Date: Friday, 7 Jun, 10:00 – 10:30 CEST
THRIVE Partner(s): ALL

Oral Presentations

Title: Antibiotic-mediated microbiota depletion limits IgA-related fibrogenesis in metabolic dysfunction-associated steatohepatitis (OS-103)
Presenter: Svenja Schuehle
Session-Type: Oral presentation
Topic: Basic Science
Room: Amber 1+2
Date: Saturday, 8 Jun, 11:30 – 11:45 CEST
THRIVE Partner(s): Prof. Mathias Heikenwälder, Prof. Eran Elinav

Poster presentations

Title: Semaglutide achieves resolution of metabolic dysfunction-associated steatohepatitis via modulation of multiple pathogenic pathways: insights from human and animal studies (LBP-003)
Presenter: Quentin M. Anstee
Session-Type: Poster
Topic: General Hepatology
Room: Poster Area
Date: Wednesday, 5 Jun, from 08:30
THRIVE Partner(s): Prof. Quentin M Anstee

Title: Analyses of fibrosis biomarkers PRO-C3 and ELF in resmetirom treated patients from MAESTRO-NASH, a 52 Week NASH/MASH serial liver biopsy study (WED-196)
Presenter: Quentin M. Anstee
Session-Type: Poster
Topic: Metabolism, Alcohol and Toxicity
Room: Poster Area
Date: Wednesday, 5 Jun, from 08:30
THRIVE Partner(s): Prof. Quentin M Anstee

Title: Single-cell RNA sequencing-derived gene signatures reveal distinct response mechanisms to atezolizumab + bevacizumab in advanced hepatocellular carcinoma (TOP-507-YI)
Presenter: Marta Piqué-Gili
Session-Type: Poster (Top)
Topic: Liver Tumours; Basic Science
Room: Poster Area
Date: Friday, 7 Jun from 08:30 CEST
THRIVE Partner(s): Prof. Josep M Llovet, Prof. Mathias Heikenwälder, Prof. Helen Reeves

Title: Efficacy of WNTinib, a novel selective therapeutic for CTNNB1 mutant tumors, in preclinical models of hepatoblastoma (FRI-467)
Presenter: Ugne Balaseviciute
Session-Type: Poster + Poster Tour
Topic: Liver Tumours; Basic Science
Room: Track Hub: Liver Tumours
Date: Friday, 7 Jun from 08:30 CEST; Tour on: Friday, 7 Jun, 13:17 – 13:25 CEST
THRIVE Partner(s): Prof. Josep M Llovet

Title: qBallooning: AI-based ballooned hepatocyte detection and quantification by second harmonic generation/two photon excitation microscopy (FRI-208)
Presenter: Dean Tai
Session-Type: Poster + Poster tour
Topic: Metabolism, Alcohol and Toxicity
Room: Track Hub: Metabolism, Alcohol & Toxicity
Date: Friday, 7 Jun, from 08:30 CEST Tour: Saturday, 8 Jun, 12:15 – 12:22 CEST
THRIVE Partner(s): Prof. Quentin M Anstee

Title: Implications and therapeutic potential of neddylation for pediatric liver cancer: hepatoblastoma
Presenter: Leidy Estefanía Zapata-Pavas
Session-Type: Poster
Topic: Liver Tumours; Basic Science
Room: Poster Area
Date: Friday, 7 Jun from 08:30 CEST
THRIVE Partner(s): Dr. Carolina Armengol

Title: Oncogenic beta-catenin is using CD155 as a molecular actor to corrupt immunosurveillance of cold HCC (TOP-552).
Presenter: Joana Gonçalves Araujo
Session-Type: Poster (Top) + Poster tour
Topic: Basic Science
Room: Track Hub: Basic Science
Date: Saturday, 8 Jun, from 08:30 CEST Tour: Saturday, 8 Jun, 12:45 – 12:55 CEST
THRIVE Partner(s): Prof. Jessica Zucman-Rossi

Symposia, Workshops and Studios

Title: EASL Studio – Advances in systemic treatments in liver cancer
Presenters: Josep M Llovet, Jessica Zucman-Rossi, Massimo Iavarone and Matthias Pinter
Session-Type: Studio
Topic: Liver Tumours
Room: EASL Studio & Hepatology Arena
Date: Wednesday, 5 Jun, 13:15 – 13:45 CEST
THRIVE Partner(s): Prof. Josep M Llovet, Prof. Jessica Zucman-Rossi

Title: YI Seminar: Shaping scientific progress – Excellence in peer review and editorial decision making (Session): What’s behind the editor‘s decision: Work behind the scenes & performance metrics
Presenter: Jessica Zucman-Rossi
Session-Type: Symposia
Topic: General Hepatology
Room: Brown 3
Date: Thursday, 6 Jun, 15:00 – 15:10 CEST
THRIVE Partner(s): Prof. Jessica Zucman-Rossi

Title: FAIR principles
Presenter: Quentin M. Anstee
Session-Type: Workshop
Topic: General Hepatology
Room: Amber 7
Date: Thursday, 6 Jun, 17:05 – 17:20 CEST
THRIVE Partner(s): Prof. Quentin M Anstee

Title: JHep Reports: New team approach
Presenter: Josep M Llovet
Session-Type: Symposia
Topic: General Hepatology
Room: Space 4
Date: Friday, 7 Jun, 15:00 – 16:00 CEST
THRIVE Partner(s): Prof. Josep M Llovet

Title: Tissue and circulating biomarkers for diagnosis and management of HCC and cholangiocarcinoma
Presenter: Jessica Zucma-Rossi (Chair), Stephanie Roessler (Chair), Valérie Paradis, Bruno Sangro, Jesús M. Bañales
Session-Type: Symposia
Topic: Liver Tumours
Room: Brown 1+2
Date: Saturday, 8 Jun, 08:30 – 09:45 CEST
THRIVE Partner(s): Prof. Jessica Zucman-Rossi

Industry sessions

Title: Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes
Presenter: Quentin M. Anstee (Chair), Lise Lotte Gluud, Kenneth Cusi
Session-Type: Industry satellite symposia
Topic: Metabolism, Alcohol and Toxicity
Room: Brown 1+2
Date: Thursday, 6 Jun, 12:45 – 13:45 CEST
THRIVE Partner(s): Prof. Quentin M Anstee

Title: AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies
Presenters: Quentin M. Anstee, Meena Bansal, Elisabetta Bugianesi
Session-Type: Industry satellite symposia
Topic: Metabolism, Alcohol and Toxicity
Room: Brown 3
Date: Friday, 7 Jun, 12:45 – 13:45 CEST
THRIVE Partner(s): Prof. Quentin M Anstee